Charles River Laboratories | Ventes

Sales Changement Date
Agilent USD 1.66B 30M 2023-12
Align Technology USD 997.4M 40.67M 2024-03
Bio-Rad Laboratories USD 681.18M 49.06M 2023-12
Bruker USD 721.7M 132.8M 2024-03
Cardinal Health USD 54.9B 2.55B 2024-03
Catalent USD 1.12B 96M 2024-03
Charles River Laboratories USD 1.01B 13.15M 2023-12
Cigna USD 57.26B 6.15B 2024-03
CVS Health USD 88.4B 5.41B 2024-03
Danaher USD 5.8B 605M 2024-03
Dentsply International USD 953M 59M 2024-03
Elevance Health 42.3B 154M 2024-03
Galapagos EUR 136.34M 29.08M 2023-09
Hologic USD 1.01B 67.8M 2023-12
Humana USD 29.33B 3.6B 2024-03
Illumina USD 1.12B 3M 2023-12
Incyte USD 880.89M 132.45M 2024-03
IQVIA Holdings USD 3.74B 128M 2024-03
Laboratory Of America USD 3.18B 146.7M 2024-03
Lonza CHF 3.64B 561M 2023-12
McKesson USD 80.9B 3.68B 2023-12
Merck EUR 14.73B 9.51B 2024-03
Mettler Toledo International USD 934.99M 7.47M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.9B 651M 2024-03
Quest Diagnostics USD 2.37B 82M 2024-03
Revvity USD 649.92M 45.98M 2024-03
Thermo Fisher Scientific USD 10.34B 546M 2024-03
United Therapeutics USD 677.7M 63M 2024-03
UnitedHealth 99.8B 5.37B 2024-03
Walgreens Boots Alliance USD 37.05B 345M 2023-12
Waters USD 819.47M 107.78M 2023-12
West Pharmaceutical Services USD 695.4M 36.6M 2024-03



Charles River Laboratories Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.